30/72
2.1 / 5 stars
All 72 Win/Lose results and 48 gray no-data contests shown below
PACB Roast Me summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth No data.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth No data.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth No data.
- 2025-Q3: Total return Lose; Revenue growth No data; EPS growth No data.
Trailing 1 year (4 quarters): 2 wins, 5 losses, 5 no dataLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/2 |
WinPACB / S&P 27.27% / 15.20% |
LosePACB / S&P 2.02% / 15.00% |
No dataPACB / S&P / 50.40% |
| 2026-Q10/2 |
LosePACB / S&P -29.41% / -4.33% |
LosePACB / S&P 5.04% / 11.30% |
No dataPACB / S&P / 27.70% |
| 2025-Q41/2 |
WinPACB / S&P 46.09% / 2.65% |
LosePACB / S&P 3.89% / 9.00% |
No dataPACB / S&P / 13.40% |
| 2025-Q30/1 |
LosePACB / S&P 3.23% / 8.12% |
No dataPACB / S&P / 4.61% |
No dataPACB / S&P / 13.45% |
| 2025-Q20/1 |
LosePACB / S&P 5.08% / 10.94% |
No dataPACB / S&P / 4.83% |
No dataPACB / S&P / 10.63% |
| 2025-Q10/1 |
LosePACB / S&P -35.52% / -4.27% |
No dataPACB / S&P / 4.98% |
No dataPACB / S&P / 10.57% |
| 2024-Q41/2 |
WinPACB / S&P 7.65% / 2.41% |
LosePACB / S&P -23.19% / 5.25% |
No dataPACB / S&P / 6.15% |
| 2024-Q31/1 |
WinPACB / S&P 24.09% / 5.89% |
No dataPACB / S&P / 5.89% |
No dataPACB / S&P / 6.11% |
| 2024-Q20/1 |
LosePACB / S&P -63.47% / 4.28% |
No dataPACB / S&P / 5.38% |
No dataPACB / S&P / 5.12% |
| 2024-Q10/1 |
LosePACB / S&P -61.77% / 10.56% |
No dataPACB / S&P / 5.71% |
No dataPACB / S&P / 5.59% |
| 2023-Q42/2 |
WinPACB / S&P 17.49% / 11.69% |
WinPACB / S&P 56.29% / 6.81% |
No dataPACB / S&P / 7.78% |
| 2023-Q30/1 |
LosePACB / S&P -37.22% / -3.27% |
No dataPACB / S&P / 7.52% |
No dataPACB / S&P / -5.03% |
| 2023-Q21/1 |
WinPACB / S&P 14.85% / 8.74% |
No dataPACB / S&P / 9.50% |
No dataPACB / S&P / -8.57% |
| 2023-Q11/1 |
WinPACB / S&P 41.56% / 7.50% |
No dataPACB / S&P / 10.77% |
No dataPACB / S&P / -15.69% |
| 2022-Q41/2 |
WinPACB / S&P 40.79% / 7.56% |
LosePACB / S&P -1.69% / 11.88% |
No dataPACB / S&P / -17.99% |
| 2022-Q31/2 |
WinPACB / S&P 31.45% / -4.88% |
LosePACB / S&P 12.61% / 13.47% |
No dataPACB / S&P / -1.41% |
| 2022-Q21/2 |
LosePACB / S&P -51.43% / -16.10% |
WinPACB / S&P 31.86% / 13.71% |
No dataPACB / S&P / 11.04% |
| 2022-Q11/2 |
LosePACB / S&P -55.52% / -4.60% |
WinPACB / S&P 45.94% / 15.97% |
No dataPACB / S&P / 42.23% |
| 2021-Q41/3 |
LosePACB / S&P -19.92% / 11.03% |
WinPACB / S&P 65.43% / 15.00% |
LosePACB / S&P -623.53% / 96.40% |
| 2021-Q31/2 |
LosePACB / S&P -26.94% / 0.58% |
WinPACB / S&P 52.63% / 10.77% |
No dataPACB / S&P / 69.42% |
| 2021-Q21/2 |
LosePACB / S&P 4.98% / 8.55% |
WinPACB / S&P 28.24% / 6.58% |
No dataPACB / S&P / 51.81% |
| 2021-Q12/2 |
WinPACB / S&P 28.41% / 6.17% |
WinPACB / S&P 2.47% / -1.06% |
No dataPACB / S&P / 7.39% |
| 2020-Q41/2 |
WinPACB / S&P 162.82% / 12.15% |
LosePACB / S&P -13.20% / -3.72% |
No dataPACB / S&P / -33.42% |
| 2020-Q31/2 |
WinPACB / S&P 186.09% / 8.93% |
LosePACB / S&P -3.39% / -2.04% |
No dataPACB / S&P / -27.10% |
| 2020-Q21/2 |
LosePACB / S&P 12.75% / 20.54% |
WinPACB / S&P 4.81% / -0.46% |
No dataPACB / S&P / -27.11% |
| 2020-Q11/2 |
LosePACB / S&P -40.47% / -19.60% |
WinPACB / S&P 18.99% / 3.47% |
No dataPACB / S&P / -14.75% |
| 2019-Q41/2 |
LosePACB / S&P -0.39% / 9.07% |
WinPACB / S&P 15.60% / 5.36% |
No dataPACB / S&P / 2.99% |
| 2019-Q30/2 |
LosePACB / S&P -14.71% / 1.70% |
LosePACB / S&P -1.84% / 5.02% |
No dataPACB / S&P / 0.21% |
| 2019-Q20/2 |
LosePACB / S&P -16.32% / 4.30% |
LosePACB / S&P -11.95% / 6.64% |
No dataPACB / S&P / 8.65% |
| 2019-Q10/2 |
LosePACB / S&P -2.30% / 13.65% |
LosePACB / S&P -13.91% / 8.12% |
No dataPACB / S&P / 14.29% |
| 2018-Q41/2 |
WinPACB / S&P 36.78% / -13.52% |
LosePACB / S&P -15.88% / 9.05% |
No dataPACB / S&P / 18.23% |
| 2018-Q31/2 |
WinPACB / S&P 52.39% / 7.71% |
LosePACB / S&P -10.84% / 10.21% |
No dataPACB / S&P / 19.06% |
| 2018-Q21/2 |
WinPACB / S&P 73.17% / 3.43% |
LosePACB / S&P -6.69% / 9.03% |
No dataPACB / S&P / 14.46% |
| 2018-Q10/2 |
LosePACB / S&P -22.35% / -0.76% |
LosePACB / S&P -8.90% / 7.68% |
No dataPACB / S&P / 12.46% |
| 2017-Q40/2 |
LosePACB / S&P -49.71% / 6.64% |
LosePACB / S&P 3.04% / 7.03% |
No dataPACB / S&P / 13.82% |
| 2017-Q31/2 |
WinPACB / S&P 47.47% / 4.48% |
LosePACB / S&P -6.93% / 5.68% |
No dataPACB / S&P / 17.57% |
| 2017-Q21/2 |
LosePACB / S&P -31.14% / 3.09% |
WinPACB / S&P 6.39% / 4.83% |
No dataPACB / S&P / 17.74% |
| 2017-Q11/2 |
WinPACB / S&P 36.05% / 6.07% |
LosePACB / S&P 2.37% / 3.67% |
No dataPACB / S&P / 13.32% |
| 2016-Q40/2 |
LosePACB / S&P -57.59% / 3.82% |
LosePACB / S&P -2.23% / 2.09% |
No dataPACB / S&P / 7.05% |
| 2016-Q32/2 |
WinPACB / S&P 27.27% / 3.85% |
WinPACB / S&P 37.96% / 0.20% |
No dataPACB / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | PACB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 5.77% | 20.78% |
| Annualized return | 5.77% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | PACB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -95.68% | 83.14% |
| Annualized return | -46.66% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | PACB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -83.31% | 319.30% |
| Annualized return | -16.39% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |